Bain Capital Life Sciences Investors, LLC - DYNAVAX TECHNOLOGIES CORP ownership

DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bain Capital Life Sciences Investors, LLC ownership history of DYNAVAX TECHNOLOGIES CORP
ValueSharesWeighting
Q3 2023$13,514,550
-56.7%
915,000
-62.1%
1.51%
-53.0%
Q2 2023$31,201,800
+81142.0%
2,415,000
-38.3%
3.21%
-33.1%
Q1 2023$38,406
-7.8%
3,915,0000.0%4.80%
+3.1%
Q4 2022$41,656
-99.9%
3,915,000
-27.7%
4.66%
-31.0%
Q3 2022$56,533,000
-46.6%
5,415,000
-35.7%
6.75%
-45.7%
Q2 2022$105,945,000
+16.1%
8,415,0000.0%12.42%
+40.3%
Q1 2022$91,219,000
-23.0%
8,415,0000.0%8.86%
-5.6%
Q4 2021$118,399,000
-26.8%
8,415,0000.0%9.39%
-6.4%
Q3 2021$161,652,000
+39.4%
8,415,000
-28.5%
10.03%
+32.0%
Q2 2021$115,951,000
+8.3%
11,771,708
+8.0%
7.60%
+25.2%
Q1 2021$107,105,000
+127.5%
10,895,7730.0%6.07%
+38.3%
Q3 2020$47,070,000
-51.3%
10,895,7730.0%4.39%
-56.7%
Q2 2020$96,646,000
+213.6%
10,895,773
+24.8%
10.12%
+94.2%
Q1 2020$30,819,000
-36.3%
8,730,707
+3.3%
5.21%
-27.7%
Q4 2019$48,347,000
+59.8%
8,452,2350.0%7.21%
-7.5%
Q3 2019$30,259,0008,452,2357.79%
Other shareholders
DYNAVAX TECHNOLOGIES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Chicago Capital, LLC 5,782,610$25,733,0001.15%
Avidity Partners Management LP 4,000,000$17,800,0000.58%
PFM Health Sciences, LP 2,936,990$13,070,0000.46%
Rhenman & Partners Asset Management AB 925,534$4,119,0000.34%
EDMOND DE ROTHSCHILD HOLDING S.A. 1,470,000$6,542,0000.22%
JACKSON SQUARE CAPITAL, LLC 122,555$545,0000.21%
Rock Springs Capital Management LP 1,649,420$7,340,0000.16%
FEDERATED HERMES, INC. 11,946,800$53,163,0000.11%
Virtus ETF Advisers LLC 57,062$254,0000.10%
GABLES CAPITAL MANAGEMENT INC. 31,225$139,0000.08%
View complete list of DYNAVAX TECHNOLOGIES CORP shareholders